Preprint
Article

This version is not peer-reviewed.

Allergen-Specific IgE Sensitization Characteristics in Patients with Allergic Skin Diseases in Southern VietNam

Submitted:

22 April 2026

Posted:

23 April 2026

You are already at the latest version

Abstract
The diverse clinical manifestations of allergic skin diseases often overlap with other pathologies, posing significant diagnostic challenges. Allergen-specific IgE (sIgE) testing is essential for identifying triggers and personalizing treatments in allergic skin diseases. A retrospective study was conducted on 4,277 medical records of patients with allergic skin diseases who underwent sIgE testing at the HCMC Hospital of Dermato-Venereology, a tertiary referral dermatology center serving Southern Vietnam, from January to December 2024. The results revealed that 64.09% of the patients exhibited sIgE sensitization. House dust mites (D. farinae: 30.91%, D. pteronyssinus: 25.67%) and fire ants (24.06%) were the predominant allergens. Food sensitization was predominantly mild, with almond being the most common (10.26%). Significantly higher sensitization severity was observed in males, young adults (12–35 years), and non-urban residents (p < 0.001). Correlation analysis demonstrated robust co-sensitization and cross-reactivity among aeroallergens, predominantly driven by house dust mites. In conclusion, allergen sensitization profiles are strongly influenced by demographic and geographic factors, with a characteristic pattern observed in Southern Vietnam. Multiplex sIgE testing provides substantial value in disease stratification, prognostic assessment, and the development of personalized treatment strategies in this tropical setting.
Keywords: 
;  ;  
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated